Danshensu modulates atherosclerosis in rats by downregulating cleaved caspase-3 protein expression, upregulating BCL-2 protein expression, reducing serum IL-6 and CRP levels, and suppressing the expression of TLR2, TLR4, p-IĸB, and NF-ĸB p65, with enhanced effects at higher doses [48]. This evidence concerns the gene IL6 and atherosclerosis.